Format

Send to

Choose Destination
Breast Cancer Res. 2006;8(2):204. Epub 2006 Apr 21.

Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective.

Author information

1
Tumour Biology Laboratory, Institute of Cancer, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London, UK. louise.j.jones@cancer.org.uk

Abstract

Ductal carcinoma in situ (DCIS) is encountered much more frequently in the screening population compared to the symptomatic setting. The behaviour of DCIS is highly variable and this presents difficulties in choosing appropriate treatment strategies for individual cases. This review discusses the current data on the frequency and rate of progression of DCIS, the value and limitations of clinicopathological and biological variables in predicting disease behaviour and suggests strategies to develop more robust means of predicting progression of DCIS.

PMID:
16677423
PMCID:
PMC1557717
DOI:
10.1186/bcr1397
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center